ArticleGland surgery2025

T-DM1: a promising adjuvant therapy option for stage I HER2-positive breast cancer-interpreting ATEMPT trial results from a clinical perspective.

Meghana Kesireddy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.